AlphAIAlphAI — Financial news for AI agents
seekingalpha.comOCT 61 min read$OPCH

OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover (OPCH:NASDAQ)

Option Care Health (OPCH) shares rose 34% after CD&R and McKesson (MCK) agreed to acquire the company for $32.05 per share, valuing it at $5.8B including debt. The deal is expected to close in 2024, subject to regulatory approval and OPCH shareholder approval.

Original reporting
seekingalpha.com
Published Oct 6, 2026, 12:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMergers & acquisitions
Primary signal
$OPCH
Bullish
high confidence
Mentioned
$OPCH · $MCK
Relevance
9/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The acquisition premium drives a sharp share rally, while McKesson's involvement may influence its balance sheet.

02

Market read

The deal represents a significant M&A event in the U.S. healthcare sector, prompting immediate price action.

03

What to watch

Financing terms and potential antitrust review may affect deal timing and valuation.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Option Care Health, a specialty pharmacy, is being taken private by a consortium led by CD&R and McKesson.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health announced a definitive agreement to be acquired for $32.05 per share, valuing it at $5.8 B and triggering a 34% jump in its stock.

Expected impact

upward pressure as the market prices in the acquisition premium

Evidence & confidence

The announced acquisition premium and immediate 34% move indicate strong buying interest.

$MCKNeutralMedium confidence
Context

McKesson is a co‑buyer in the $5.8 B acquisition of Option Care Health, making it a direct party to the deal.

Expected impact

neutral to slight pressure as investors assess financing and integration costs

Evidence & confidence

Acquisition adds exposure to specialty pharmacy but may be offset by financing considerations.

Market effects

Sector

Consolidation in the specialty pharmacy sector may lift peers.

Regional

U.S. healthcare M&A activity gains momentum.

Global

Highlights continued appetite for large‑scale health‑care deals worldwide.

Counterpoint

What could challenge this read

Deal could face regulatory scrutiny or integration risk, tempering upside.

Key entities

  • Company
    Option Care Health

    Target of the $5.8 B acquisition.

  • Company
    McKesson

    Co‑buyer in the acquisition.

  • Private equity firm
    CD&R

    Lead investor in the deal.

Read at source← All news

Also covered by

5 outlets

Related articles

OCT 7
$OPCHHighAI 9/10

Infusion therapy provider being acquired in $5.8 billion deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson in a $5.8 billion deal, expected to close in early 2027. CD&R will hold majority ownership, with McKesson holding a minority stake. Option Care Health shares were trading at $31.02, up from $23.34 before the acquisition news. The company will remain separate but will delist from Nasdaq post-deal.

wfmz.com2 min
OCT 7
$OPCHHighAI 9/10

Option Care stock surges on McKesson's home-infusion bet

Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.

finance.yahoo.com2 min
OCT 7
$MCKHighAI 9/10

McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout

McKesson plans a $1.4B investment for a 49% stake in Option Care Health, part of a $5.8B buyout by Clayton, Dubilier & Rice. Shareholders will receive $32.05 per share. The deal, pending approvals, is expected to close in early 2027. Option Care shares rose 32.7% on the news. McKesson's Q1 revenue grew 8% to $105.4B, with net income down 22% to $614M.

finchannel.com2 min